[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  BiopharmIQ by Amp [@BiopharmIQ](/creator/twitter/BiopharmIQ) on x 25.7K followers Created: 2025-07-07 16:06:15 UTC 📌 Biotech Stock News 7/7 @ Open 🧬 📰 $COGT XX% Topline Results from SUMMIT Trial $KALV XX% FDA Approves First Oral Treatment for Hereditary Angioedema $FBIO X% Granted Orphan Drug Designation for CAR T-cells $COLL X% $150M Share Repurchase Program $LXEO X% Breakthrough Therapy Designation for LX2006 $ALUR X% Submission of PMA and Study Analyses $URGN X% Completion of Ph3 UTOPIA Trial $ALC X% Acquires LumiThera and Asset for Wet AMD Treatment $BSX X% FDA Approval for Expanded Labeling $NTRA -X% Data on Tissue-Free MRD Assay $DNLI -X% FDA Acceptance and Priority Review for BLA $NRIX -X% Orphan Drug Designation for Bexobrutideg $LENZ -X% License and Commercialization Agreement for LNZ100 $AGEN -X% Two-Year Survival Data in CRC $APGE -XX% 16-Week Data from Ph2 Trial $JSPR -XX% Clinical Data Update on Briquilimab See image for more details. 📸 $APGE down after release of 16-wk Ph2 data. See post from @BowTiedBiotech for more info 👀 XXXXX engagements  **Related Topics** [money](/topic/money) [Sentiment](/topic/sentiment) [$urgn](/topic/$urgn) [$alur](/topic/$alur) [breakthrough](/topic/breakthrough) [$lxeo](/topic/$lxeo) [$150m](/topic/$150m) [$coll](/topic/$coll) [Post Link](https://x.com/BiopharmIQ/status/1942253838402289849)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
BiopharmIQ by Amp @BiopharmIQ on x 25.7K followers
Created: 2025-07-07 16:06:15 UTC
📌 Biotech Stock News 7/7 @ Open 🧬 📰
$COGT XX% Topline Results from SUMMIT Trial $KALV XX% FDA Approves First Oral Treatment for Hereditary Angioedema $FBIO X% Granted Orphan Drug Designation for CAR T-cells $COLL X% $150M Share Repurchase Program $LXEO X% Breakthrough Therapy Designation for LX2006 $ALUR X% Submission of PMA and Study Analyses
$URGN X% Completion of Ph3 UTOPIA Trial $ALC X% Acquires LumiThera and Asset for Wet AMD Treatment $BSX X% FDA Approval for Expanded Labeling
$NTRA -X% Data on Tissue-Free MRD Assay $DNLI -X% FDA Acceptance and Priority Review for BLA $NRIX -X% Orphan Drug Designation for Bexobrutideg $LENZ -X% License and Commercialization Agreement for LNZ100 $AGEN -X% Two-Year Survival Data in CRC $APGE -XX% 16-Week Data from Ph2 Trial $JSPR -XX% Clinical Data Update on Briquilimab See image for more details. 📸
$APGE down after release of 16-wk Ph2 data. See post from @BowTiedBiotech for more info 👀
XXXXX engagements
Related Topics money Sentiment $urgn $alur breakthrough $lxeo $150m $coll
/post/tweet::1942253838402289849